Antipsychotics in Pregnancy Double Diabetes Risk, Researchers Say
Women who take antipsychotic drugs during pregnancy are much more likely to develop diabetes and give birth to smaller babies, researchers report.
Women who take antipsychotic drugs during pregnancy are much more likely to develop diabetes and give birth to smaller babies, researchers report.
Scientists at the University of Uppsala in Sweden reviewed data on nearly 360,000 Swedish women who gave birth between 2005 and 2009. Antipsychotic drug use among those women was uncommon, with only 507 recorded as having taken them.
The two drugs found to be most commonly associated with “adverse metabolic effects” were Zyprexa and Clozaril.
— Posted by Alexander Reed Kelly
WAIT BEFORE YOU GO...MedPage Today:
Analysis of Swedish national birth and health registry data showed that, relative to mothers-to-be not taking antipsychotic drugs, the risk of gestational diabetes was nearly doubled, according to Robert Bodén, MD, PhD, of Uppsala University in Uppsala, Sweden, and colleagues.
… Bodén and colleagues explained that babies born large for gestational age have previously been associated with gestational diabetes. Because the fetus is not insulin resistant, the high levels of sugar to which it is exposed prompt high levels of insulin secretion, which, in turn, produces macrosomia and increased fetal size.
This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.
At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.
Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.
Don’t settle for surface-level coverage.
Unearth what matters. Help dig deeper.
Donate now.
Editorial Cartoons
By manufacturing in such poorly regulated countries as China and India, the industry risks that our drugs may be laced with carcinogens.
The presidential candidate travels with a caravan of type 1 diabetes patients seeking affordable insulin in America's northern neighbor.
“It felt like we were robbing the pharmacy,” one buyer says of the low prices she paid in Canada.
The Trump administration should veto the chemical giants' pending merger to protect not just competitors but human and environmental health.
"Less efficient" sleep might explain racial disparities in the risk for certain diseases, especially in women.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.